Skip to Main content Skip to Navigation
Journal articles

Development and validation of serological markers for detecting recent Plasmodium vivax infection

Abstract : A major gap in the Plasmodium vivax elimination toolkit is the identification of individuals carrying clinically silent and undetectable liver-stage parasites, called hypnozoites. This study developed a panel of serological exposure markers capable of classifying individuals with recent P. vivax infections who have a high likelihood of harboring hypnozoites. We measured IgG antibody responses to 342 P. vivax proteins in longitudinal clinical cohorts conducted in Thailand and Brazil and identified candidate serological markers of exposure. Candidate markers were validated using samples from year-long observational cohorts conducted in Thailand, Brazil and the Solomon Islands and antibody responses to eight P. vivax proteins classified P. vivax infections in the previous 9 months with 80% sensitivity and specificity. Mathematical models demonstrate that a serological testing and treatment strategy could reduce P. vivax prevalence by 59-69%. These eight antibody responses can serve as a biomarker, identifying individuals who should be targeted with anti-hypnozoite therapy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [84 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-02612720
Contributor : Thomas Obadia <>
Submitted on : Friday, May 29, 2020 - 2:16:27 PM
Last modification on : Friday, October 16, 2020 - 4:08:02 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2020-11-11

Please log in to resquest access to the document

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

Citation

Rhea Longley, Michael White, Eizo Takashima, Jessica Brewster, Masayuki Morita, et al.. Development and validation of serological markers for detecting recent Plasmodium vivax infection. Nature Medicine, Nature Publishing Group, 2020, 26 (5), pp.741-749. ⟨10.1038/s41591-020-0841-4⟩. ⟨pasteur-02612720⟩

Share

Metrics

Record views

39